Conference
New DCE-MRI Parameters to Quantify the Vascular Changes Induced by Sunitinib Treatment in Renal Carcinoma Tumors* *Resrach supported by Pfizer.
Abstract
To develop new dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) parameters to quantify the vascular effects of different doses of the antiangiogenic drug sunitinib on renal cell carcinoma (RCC) kidney tumors in mice. Mice bearing established RCC xenograft tumors were treated with sunitinib doses of 10, 20 or 40 mg/kg/day (SU10, SU20 or SU40 respectively) or treated with vehicle only (control). New DCE parameters, contrast agent …
Authors
Al-Bashir AK; Hillman GG; Li M; Katkuri Y; Singh-Gupta V; Shen Y; Yunker CK; Haacke EM
Pagination
pp. 9-12
Publisher
Institute of Electrical and Electronics Engineers (IEEE)
Publication Date
February 1, 2014
DOI
10.1109/mecbme.2014.6783195
Name of conference
2nd Middle East Conference on Biomedical Engineering